Literature DB >> 9609459

A high glucose concentration stimulates the expression of monocyte chemotactic peptide 1 in human mesangial cells.

C G Ihm1, J K Park, S P Hong, T W Lee, B S Cho, M J Kim, D R Cha, H Ha.   

Abstract

The mechanism of glomerular infiltration of monocytes remains unknown in diabetic nephropathy. We examined the effect of a high glucose concentration on monocyte chemotactic peptide 1 (MCP-1) expression in human mesangial cells (MCs) by using enzyme-linked immunosorbent assay and reverse transcription coupled with polymerase chain reaction (PCR). More than a 50% increase in the MCP-1 protein production was observed in MCs cultured in high-glucose medium (450 mg/dl) as compared to normal glucose (100 mg/dl; 1,496 +/- 75 vs. 966 +/- 15 pg/ml after 24 h, 1,910 +/- 93 vs. 1,250 +/- 55 pg/ml after 48 h). Semiquantitative PCR showed that phorbol myristate acetate (100 nM) increased the ratio of PCR products for MCP-1 to housekeeping gene glyceraldehyde-3-phosphate dehydrogenase on densitometric results at 24 h by 2.7-fold, which was prevented by calphostin C (200 nM) pretreatment. High glucose increased the ratio by 3-fold as compared to normal glucose at 24 h (0.72 +/- 0.11 vs. 0.24 +/- 0.01). This was also suppressed by calphostin C pretreatment. These findings demonstrate that high glucose can directly increase MCP-1 expression in MCs, which may contribute to monocyte infiltration in diabetic nephropathy, and this is regulated by protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9609459     DOI: 10.1159/000044988

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  24 in total

1.  Renoprotective effects of clarithromycin via reduction of urinary MCP-1 levels in type 2 diabetic patients.

Authors:  Atsuhito Tone; Kenichi Shikata; Koichi Nakagawa; Masaaki Hashimoto; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2010-11-03       Impact factor: 2.801

Review 2.  New molecular insights in diabetic nephropathy.

Authors:  Ionel Alexandru Checheriţă; Gina Manda; Mihai Eugen Hinescu; Ileana Peride; Andrei Niculae; Ştefana Bîlha; Angelica Grămăticu; Luminiţa Voroneanu; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2016-01-12       Impact factor: 2.370

3.  MCP-1 and MIP-2 expression and production in BB diabetic rat: effect of chronic hypoxia.

Authors:  Cacchio Marisa; Isabella Lucci; Camillo Di Giulio; Giuseppina Bianchi; Alfredo Grilli; Antonia Patruno; Marcella Reale
Journal:  Mol Cell Biochem       Date:  2005-08       Impact factor: 3.396

Review 4.  Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.

Authors:  Federica Barutta; Graziella Bruno; Serena Grimaldi; Gabriella Gruden
Journal:  Endocrine       Date:  2014-10-02       Impact factor: 3.633

5.  Gingival levels of monocyte chemoattractant protein-1 (MCP-1) in diabetes mellitus and periodontitis: an experimental study in rats.

Authors:  Elif Eser Sakallioğlu; Bülent Ayas; Müge Lütfioğlu; Gonca Cayir Keleş; Gökhan Açikgöz; Erhan Firatli
Journal:  Clin Oral Investig       Date:  2007-09-18       Impact factor: 3.573

6.  Preventive effect of cerivastatin on diabetic nephropathy through suppression of glomerular macrophage recruitment in a rat model.

Authors:  T Ota; T Takamura; H Ando; E Nohara; H Yamashita; K Kobayashi
Journal:  Diabetologia       Date:  2003-05-27       Impact factor: 10.122

7.  Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial.

Authors:  Girish N Nadkarni; Veena Rao; Faramarz Ismail-Beigi; Vivian A Fonseca; Sudhir V Shah; Michael S Simonson; Lloyd Cantley; Prasad Devarajan; Chirag R Parikh; Steven G Coca
Journal:  Clin J Am Soc Nephrol       Date:  2016-05-17       Impact factor: 8.237

8.  Resting Heart Rate Variability, Inflammation, and Insulin Resistance in Overweight and Obese Adolescents.

Authors:  Roy C Parish; Steven Todman; Sushil K Jain
Journal:  Metab Syndr Relat Disord       Date:  2016-05-16       Impact factor: 1.894

9.  MCP-1 and RANTES polymorphisms in Korean diabetic end-stage renal disease.

Authors:  Kwon Wook Joo; Young Hwan Hwang; Jae Hyeon Kim; Kook Hwan Oh; Hyunho Kim; Hyoung Doo Shin; Woo Kyung Chung; Jaeseok Yang; Kyong Soo Park; Curie Ahn
Journal:  J Korean Med Sci       Date:  2007-08       Impact factor: 2.153

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.